YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Glenmark Pharma

Glenmark Pharma

BSE: 532296|NSE: GLENMARK|ISIN: INE935A01035|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 13, 16:00
511.95
13.6 (2.73%)
VOLUME 319,712
LIVE
NSE
Apr 13, 15:59
511.35
13.4 (2.69%)
VOLUME 4,027,905
News on Glenmark Pharma
Select Year: 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Glenmark Pharmaceuticals gets USFDA nod for generic antipsychotic drug

1.47 pm | 24 Mar 2021 |  Source: PTI

"The company has received approval from the United States Food and Drug Administration (USFDA) for Chlorpromazine Hydrochloride tablets USP, in the st...

Glenmark Pharma share price gains on USFDA nod for Chlorpromazine Hydrochloride tablets

10.33 am | 24 Mar 2021 |  Source: Moneycontrol.com

The share touched a 52-week high of Rs 572.70 and a 52-week low of Rs 184 on 22 June, 2020 and 23 March, 2020, respectively....

Glenmark gets $40 million COVID credit line from International Finance Corporation

2.42 pm | 23 Mar 2021 |  Source: PTI

The loan to Glenmark will help it increase the availability of affordable, quality medicines in the country as well in other countries, including trea...

Glenmark gets USFDA nod for generic high blood pressure drug

2.33 pm | 23 Mar 2021 |  Source: PTI

The company has received final approval from the United States Food & Drug Administration (USFDA) for Diltiazem Hydrochloride extended-release capsule...

Glenmark joins hands with Bausch to commercialise nasal spray in Canada

2.09 pm | 22 Mar 2021 |  Source: PTI

The company's subsidiary, Glenmark Specialty SA in Switzerland and an affiliate of Bausch Health Companies Inc have entered into an exclusive lice...

Glenmark Pharma looking to unlock value of API arm via IPO route in 2021

2.23 pm | 09 Mar 2021 |  Source: Moneycontrol.com

The Glenmark IPO plan is being seen as a value unlocking exercise by the promoters. Investors will have the option or flexibility of betting on a pure...

Buy Glenmark Pharmaceuticals; target of Rs 635: ICICI Direct

4.32 pm | 17 Feb 2021 |  Source: Moneycontrol.com

ICICI Direct is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 635 in its research report dated...

Glenmark Standalone December 2020 Net Sales at Rs 1,972.48 crore, up 8.6% Y-o-Y

1.11 pm | 16 Feb 2021 |  Source: Moneycontrol.com

NULL...

Glenmark Pharmaceuticals Q3 PAT seen up 27.4% YoY to Rs. 190.8 cr: Prabhudas Lilladher

11.11 pm | 18 Jan 2021 |  Source: Moneycontrol.com

Net Sales are expected to increase by 5.5 percent Y-o-Y (down 4.3 percent Q-o-Q) to Rs. 2,638.6 crore, according to Prabhudas Lilladher....

Buy Glenmark Pharmaceuticals: target of Rs 635: ICICI Direct

6.13 pm | 12 Nov 2020 |  Source: Moneycontrol.com

ICICI Direct is bullish on Glenmark Pharmaceuticals recommended buy rating on the stock with a target price of Rs 635 in its research report dated Nov...

1 2
Quick Links for Glenmark Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.